A maintenance dose of atazanavir/ritonavir 200/100 mg once daily is effective in virologically suppressed HIV-1-infected patients

Massimiliano Lanzafame, Emanuela Lattuada, Fabio Rigo, Sandro Vento

Research output: Contribution to journalLetterpeer-review

3 Citations (Scopus)
Original languageEnglish
Pages (from-to)e81-e82
JournalJournal of Acquired Immune Deficiency Syndromes
Issue number2
Publication statusPublished - Jun 1 2013

ASJC Scopus subject areas

  • Infectious Diseases
  • Pharmacology (medical)

Cite this